十九大开幕,习近平:坚持中西医并重,传承发展中医药事业

2017-10-18 朱蕗鋆 中国中医

10月18日,中国共产党第十九次全国代表大会在北京人民大会堂隆重开幕。习近平代表第十八届中央委员会向大会作报告。

10月18日,中国共产党第十九次全国代表大会在北京人民大会堂隆重开幕。习近平代表第十八届中央委员会向大会作报告。

新华社北京10月18日电  习近平同志在十九大报告中提出,提高保障和改善民生水平,加强和创新社会治理。

习近平指出,为什么人的问题,是检验一个政党、一个政权性质的试金石。必须始终把人民利益摆在至高无上的地位,让改革发展成果更多更公平惠及全体人民,朝着实现全体人民共同富裕不断迈进。

他说,要抓住人民最关心最直接最现实的利益问题,既尽力而为,又量力而行,一件事情接着一件事情办,一年接着一年干。坚持人人尽责、人人享有,坚守底线、突出重点、完善制度、引导预期,完善公共服务体系,保障群众基本生活,不断满足人民日益增长的美好生活需要,不断促进社会公平正义,形成有效的社会治理、良好的社会秩序,使人民获得感、幸福感、安全感更加充实、更有保障、更可持续。

一是优先发展教育事业。

要全面贯彻党的教育方针,落实立德树人根本任务,发展素质教育,推进教育公平,培养德智体美全面发展的社会主义建设者和接班人。推动城乡义务教育一体化发展,高度重视农村义务教育,办好学前教育、特殊教育和网络教育,普及高中阶段教育,努力让每个孩子都能享有公平而有质量的教育。完善职业教育和培训体系,深化产教融合、校企合作。加快一流大学和一流学科建设,实现高等教育内涵式发展。健全学生资助制度,使绝大多数城乡新增劳动力接受高中阶段教育、更多接受高等教育。支持和规范社会力量兴办教育。加强师德师风建设,培养高素质教师队伍,倡导全社会尊师重教。办好继续教育,加快建设学习型社会,大力提高国民素质。

二是提高就业质量和人民收入水平。

要坚持就业优先战略和积极就业政策,实现更高质量和更充分就业。大规模开展职业技能培训,注重解决结构性就业矛盾,鼓励创业带动就业。提供全方位公共就业服务,促进高校毕业生等青年群体、农民工多渠道就业创业。破除妨碍劳动力、人才社会性流动的体制机制弊端,使人人都有通过辛勤劳动实现自身发展的机会。完善政府、工会、企业共同参与的协商协调机制,构建和谐劳动关系。坚持按劳分配原则,完善按要素分配的体制机制,促进收入分配更合理、更有序。鼓励勤劳守法致富,扩大中等收入群体,增加低收入者收入,调节过高收入,取缔非法收入。坚持在经济增长的同时实现居民收入同步增长、在劳动生产率提高的同时实现劳动报酬同步提高。拓宽居民劳动收入和财产性收入渠道。履行好政府再分配调节职能,加快推进基本公共服务均等化,缩小收入分配差距。

三是加强社会保障体系建设。

全面建成覆盖全民、城乡统筹、权责清晰、保障适度、可持续的多层次社会保障体系。全面实施全民参保计划。完善城镇职工基本养老保险和城乡居民基本养老保险制度,尽快实现养老保险全国统筹。完善统一的城乡居民基本医疗保险制度和大病保险制度。完善失业、工伤保险制度。建立全国统一的社会保险公共服务平台。统筹城乡社会救助体系,完善最低生活保障制度。坚持男女平等基本国策,保障妇女儿童合法权益。完善社会救助、社会福利、慈善事业、优抚安置等制度,健全农村留守儿童和妇女、老年人关爱服务体系。发展残疾人事业,加强残疾康复服务。坚持房子是用来住的、不是用来炒的定位,加快建立多主体供给、多渠道保障、租购并举的住房制度,让全体人民住有所居。

四是坚决打赢脱贫攻坚战。

要动员全党全国全社会力量,坚持精准扶贫、精准脱贫,坚持中央统筹省负总责市县抓落实的工作机制,强化党政一把手负总责的责任制,坚持大扶贫格局,注重扶贫同扶志、扶智相结合,深入实施东西部扶贫协作,重点攻克深度贫困地区脱贫任务,确保到二〇二〇年我国现行标准下农村贫困人口实现脱贫,贫困县全部摘帽,解决区域性整体贫困,做到脱真贫、真脱贫。

五是实施健康中国战略。

要完善国民健康政策,为人民群众提供全方位全周期健康服务。深化医药卫生体制改革,全面建立中国特色基本医疗卫生制度、医疗保障制度和优质高效的医疗卫生服务体系,健全现代医院管理制度。加强基层医疗卫生服务体系和全科医生队伍建设。全面取消以药养医,健全药品供应保障制度。坚持预防为主,深入开展爱国卫生运动,倡导健康文明生活方式,预防控制重大疾病。实施食品安全战略,让人民吃得放心。坚持中西医并重,传承发展中医药事业。支持社会办医,发展健康产业。促进生育政策和相关经济社会政策配套衔接,加强人口发展战略研究。积极应对人口老龄化,构建养老、孝老、敬老政策体系和社会环境,推进医养结合,加快老龄事业和产业发展。

六是打造共建共治共享的社会治理格局。

加强社会治理制度建设,完善党委领导、政府负责、社会协同、公众参与、法治保障的社会治理体制,提高社会治理社会化、法治化、智能化、专业化水平。加强预防和化解社会矛盾机制建设,正确处理人民内部矛盾。健全公共安全体系,完善安全生产责任制,坚决遏制重特大安全事故,提升防灾减灾救灾能力。加快社会治安防控体系建设,依法打击和惩治黄赌毒黑拐骗等违法犯罪活动,保护人民人身权、财产权、人格权。加强社会心理服务体系建设,培育自尊自信、理性平和、积极向上的社会心态。加强社区治理体系建设,推动社会治理重心向基层下移,发挥社会组织作用,实现政府治理和社会调节、居民自治良性互动。

七是有效维护国家安全。

要完善国家安全战略和国家安全政策,坚决维护国家政治安全,统筹推进各项安全工作。健全国家安全体系,加强国家安全法治保障,提高防范和抵御安全风险能力。严密防范和坚决打击各种渗透颠覆破坏活动、暴力恐怖活动、民族分裂活动、宗教极端活动。加强国家安全教育,增强全党全国人民国家安全意识,推动全社会形成维护国家安全的强大合力。

习近平强调,党的一切工作必须以最广大人民根本利益为最高标准。要坚持把人民群众的小事当作自己的大事,从人民群众关心的事情做起,从让人民群众满意的事情做起,带领人民不断创造美好生活。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
    2018-07-09 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
    2017-10-29 1e145228m78(暂无匿称)

    学习了谢谢作者分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
    2017-10-20 cathymary
  7. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1675550, encodeId=7c9a16e5550b7, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Mon Jul 09 08:11:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636271, encodeId=ed4716362e1a6, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Wed Oct 03 07:11:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906137, encodeId=eb52190613eda, content=<a href='/topic/show?id=673223521cc' target=_blank style='color:#2F92EE;'>#习近平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23521, encryptionId=673223521cc, topicName=习近平)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Mon Feb 19 06:11:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978067, encodeId=e13519e8067ab, content=<a href='/topic/show?id=5bca258e611' target=_blank style='color:#2F92EE;'>#传承发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25876, encryptionId=5bca258e611, topicName=传承发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sun Nov 26 01:11:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257019, encodeId=9bff25e01943, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Oct 29 19:32:55 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409123, encodeId=26de14091231a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463026, encodeId=57ca1463026cf, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557965, encodeId=4f96155e965cf, content=<a href='/topic/show?id=9d09214948d' target=_blank style='color:#2F92EE;'>#中医药事业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21494, encryptionId=9d09214948d, topicName=中医药事业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=549e14938166, createdName=amy0555, createdTime=Fri Oct 20 13:11:00 CST 2017, time=2017-10-20, status=1, ipAttribution=)]

相关资讯

讲真!十九大报告提出健全现代医院管理制度

习近平同志在十九大报告中指出,健全现代医院管理制度,全面取消以药养医,支持社会办医,发展健康产业。

十九大报告:实施健康中国战略 深化医药卫生体制改革

中国共产党第十九次全国代表大会18日在北京人民大会堂隆重开幕。

十九大代表杜丽群:抗艾一线十余载 护理患者过万名

对艾滋病患者的护理,大大增加了职业暴露风险,杜丽群和她的团队每天像“在刀尖上起舞”般护理着艾滋病人。

十九大报告提出:实施健康中国战略 全面取消以药养医

10月18日,中国共产党第十九次全国代表大会在北京人民大会堂隆重开幕。习近平代表第十八届中央委员会向大会作报告。

十九大提出的10条医疗卫生大计

中国共产党第十九次全国代表大会18日上午在人民大会堂开幕。习近平总书记代表第十八届中央委员会向大会作了题为《决胜全面建成小康社会 夺取新时代中国特色社会主义伟大胜利》的报告。在3个多小时的报告中,习近平总书记围绕着新时代中国特色社会主义思想和基本方略,决胜全面建成小康社会,开启全面建设社会主义现代化国家新征程,坚定文化自信,推动社会主义文化繁荣兴盛,提高保障和改善民生水平,加强和创新社会治理等十三